Researchers complete Gardasil 9 HPV vaccine’s international phase 2/3 trial
The international phase 2/3 clinical trial, which involved Moffitt Cancer Center faculty, demonstrated that Gardasil 9 vaccination can protect against nine HPV types, seven of which cause most